Free. Unsubscribe any time.
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 10 transactions and 119,122 shares. 6 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-24, came 49 days after the one before it (2026-07-06) and reports 2 transactions against 1 in the filing before it.
- The sales it reports total 22,675 shares, 17,998 more than the 4,677 in the filing before it.
- Its 6 plan statements rank 431st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 6 filings on file run from 2025-01-31 to 2026-08-24, and state 5 plan adoption dates, from 2024-09-27 to 2026-05-21.
Trades in Intellia Therapeutics, Inc. 10
- Bhanji Muna — 2025-01-29 · S · 265 shares
- Bhanji Muna — 2025-04-29 · S · 265 shares
- GOODMAN JESSE — 2025-06-30 · S · 1,547 shares
- GOODMAN JESSE — 2025-07-01 · S · 1,547 shares
- LEONARD JOHN M — 2025-12-11 · S · 49,959 shares
- LEONARD JOHN M — 2025-12-11 · S · 32,832 shares
- LEONARD JOHN M — 2025-12-11 · S · 5,355 shares
- Dulac Edward J III — 2026-07-02 · S · 4,677 shares
- LEONARD JOHN M — 2026-08-20 · S · 19,890 shares
- LEONARD JOHN M — 2026-08-21 · S · 2,785 shares
Adoption dates in Intellia Therapeutics, Inc. 5
- 2024-09-27 — stated in 2 filings
- 2025-03-31 — stated in 1 filing
- 2025-09-08 — stated in 1 filing
- 2025-09-11 — stated in 1 filing
- 2026-05-21 — stated in 1 filing
Results prints in Intellia Therapeutics, Inc. 9
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-04-30
- 2026-05-11
- 2026-08-06
Trades before a print in Intellia Therapeutics, Inc. 0
- 9 days before the 2025-05-08 print — 2025-04-29 · S · Bhanji Muna · 265 shares
- 29 days before the 2025-02-27 print — 2025-01-29 · S · Bhanji Muna · 265 shares
- 35 days before the 2026-08-06 print — 2026-07-02 · S · Dulac Edward J III · 4,677 shares
- 37 days before the 2025-08-07 print — 2025-07-01 · S · GOODMAN JESSE · 1,547 shares
- 38 days before the 2025-08-07 print — 2025-06-30 · S · GOODMAN JESSE · 1,547 shares
- 77 days before the 2026-02-26 print — 2025-12-11 · S · LEONARD JOHN M · 49,959 shares
- 77 days before the 2026-02-26 print — 2025-12-11 · S · LEONARD JOHN M · 32,832 shares
- 77 days before the 2026-02-26 print — 2025-12-11 · S · LEONARD JOHN M · 5,355 shares
Interval to Intellia Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 1within 10 days
- 9shortest, days
- 2no later print
- Bhanji Muna 2025-04-29 · S · 9 days before the 2025-05-08 print
Adoption dates Intellia Therapeutics, Inc. states
- 2024-09-27 in 2 filings
- 2025-03-31 in 1 filing
- 2025-09-08 in 1 filing
- 2025-09-11 in 1 filing
- 2026-05-21 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on September 27, 2024”
Reported results dates on file
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-04-30
- 2026-05-11
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.